Safety and efficacy of prolonged use of dalbavancin in bone and joint infections.

Conclusion: The results show that dalbavancin is a well-tolerated antibiotic, even when administering > 2 doses, and is associated with a high cure rate. This is preliminary data with a short follow-up, therefore, it is necessary to have more experience and in the future to establish the most appropriate dose and frequency.
PMID: 30858217 [PubMed - as supplied by publisher]

Source: Antimicrobial Agents and Chemotherapy - March 10, 2019 Category: Microbiology Authors: Morata L, Cobo J, Fernández-Sampedro M, Vasco PG, Ruano E, Lora-Tamayo J, Sánchez Somolinos M, Ruano PG, Nieto AR, Arnaiz A, Estébanez Muñoz M, Jiménez-Mejías ME, Lozano Serrano AB, Múñez E, Rodriguez-Pardo D, Argelich R, Arroyo A, Barbero JM, Cua Tags: Antimicrob Agents Chemother Source Type: research